Supplemental Financial Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Accrued research and development	$ 11,895	$ 2,106
Accrued compensation	7,703	1,766
Accrued license fees	3,500
Accrued property, plant, and equipment	2,644	173
Accrued clinical trials	1,659
Accrued professional and consulting fees	1,091	999
Other	1,491	91
Total accrued expenses and other current liabilities	$ 29,983	$ 5,135